Study in Healthy Volunteers to Document Safety and Tolerability of Increasing Doses Pemirolast

NCT02517372 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

RSPR Pharma AB